- Home
- RNW vs APLS Comparison
RNW vs APLS Comparison
Compare RNW & APLS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RNW
- APLS
- Stock Information
- Founded
- RNW 2011
- APLS 2009
- Country
- RNW United Kingdom
- APLS United States
- Employees
- RNW N/A
- APLS N/A
- Industry
- RNW Electric Utilities: Central
- APLS Biotechnology: Pharmaceutical Preparations
- Sector
- RNW Utilities
- APLS Health Care
- Exchange
- RNW Nasdaq
- APLS Nasdaq
- Market Cap
- RNW 2.4B
- APLS 2.2B
- IPO Year
- RNW N/A
- APLS 2017
- Fundamental
- Price
- RNW $7.55
- APLS $19.91
- Analyst Decision
- RNW Strong Buy
- APLS Buy
- Analyst Count
- RNW 1
- APLS 19
- Target Price
- RNW $7.50
- APLS $37.39
- AVG Volume (30 Days)
- RNW 1.4M
- APLS 1.9M
- Earning Date
- RNW 08-14-2025
- APLS 07-31-2025
- Dividend Yield
- RNW N/A
- APLS N/A
- EPS Growth
- RNW 16.07
- APLS N/A
- EPS
- RNW 0.13
- APLS N/A
- Revenue
- RNW $1,135,947,896.00
- APLS $775,839,000.00
- Revenue This Year
- RNW N/A
- APLS $1.01
- Revenue Next Year
- RNW $17.90
- APLS $22.14
- P/E Ratio
- RNW $59.64
- APLS N/A
- Revenue Growth
- RNW 19.36
- APLS 48.04
- 52 Week Low
- RNW $5.15
- APLS $16.10
- 52 Week High
- RNW $7.67
- APLS $42.47
- Technical
- Relative Strength Index (RSI)
- RNW 65.80
- APLS 62.09
- Support Level
- RNW $7.41
- APLS $17.35
- Resistance Level
- RNW $6.94
- APLS $19.63
- Average True Range (ATR)
- RNW 0.17
- APLS 0.81
- MACD
- RNW 0.05
- APLS 0.23
- Stochastic Oscillator
- RNW 88.21
- APLS 80.24
About RNW ReNew Energy Global plc
ReNew Energy Global PLC is a developer and operator of clean energy projects intended to meet India's growing energy needs in an efficient, sustainable and socially responsible manner. The company provides end-to-end solutions in a just and inclusive manner in the areas of clean energy, value-added energy offerings through digitalization, storage, and carbon markets that increasingly are integral to addressing climate change. The company has four reportable segments: wind power and solar power, hydro power and transmission line. It derives maximum revenue from Wind Power segment.
About APLS Apellis Pharmaceuticals Inc.
Apellis Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the discovery, development, and commercialization of novel therapeutic compounds to treat diseases with high unmet needs through the inhibition of the complement system, which is an integral component of the immune system, at the level of C3, the central protein in the complement cascade.